Prognostic model of the adaptive changes from hypertensive cardiopathy: from mild diastolic dysfunction to depressed

Alexis Álvarez-Aliaga1, Adonis Frómeta-Guerra2, Alexis Suárez-Quesada3

  • 1Hospital General Universitario Carlos Manuel de Céspedes, Bayamo, Granma, Cuba. Universidad de Ciencias Médicas de Granma, Bayamo, Cuba. Email: alexis.grm@infomed.sld.cu. ORCID: 0000-0002-4706-3821.

Medwave
|May 30, 2020
PubMed

Insights

A new model predicts hypertensive cardiopathy progression over ten years. Poor blood pressure control and hypertension stage 2 are key risk factors for developing cardiac changes.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Predictive Modeling in Medicine

Background:

  • Hypertensive cardiopathy involves heart changes due to chronic high blood pressure.
  • It is a significant component of cardiovascular diseases linked to hypertension.

Purpose of the Study:

  • To develop and validate a predictive model for adaptive changes in hypertensive cardiopathy.
  • The model aims to forecast these changes within a decade of diagnosis.

Main Methods:

  • A prospective cohort study of hypertensive patients in Cuba (2008-2018).
  • Utilized Cox proportional regression to identify prognostic factors.
  • Internal validation included discriminant capacity (C-statistic) and calibration (Hosmer-Lemeshow).

Main Results:

  • The model identified significant prognostic factors for adaptive changes.
  • Lack of blood pressure control (HR: 2.090) and hypertension stage 2 (HR: 1.987) were primary predictors.
  • Model validation showed acceptable discriminant capacity (C-statistic: 0.897).

Conclusions:

  • A validated model can predict hypertensive cardiopathy progression (Grade I to IV).
  • Key predictors include arterial hypertension effects, diabetes mellitus, and chronic kidney disease.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
577
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
216
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
362
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
218